The company’s promising guidance also instills confidence in the stock. However, significant gross margin contractions caused by escalating costs are concerns. Zacks Rank & Key Picks Integra LifeSciences has a Zacks Rank #3 (Hold). …
A year ago, they were trading at $9.73. This story was generated by Automated Insights using data from Zacks Investment Research. Access a Zacks stock report on CBL at https://www.zacks.com/ap/CBL
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LOGM at https://www.zacks.com/ap/LOGM
Non-GAAP loss per share is projected to be between $1.40 and $1.65. Zacks Rank & Stock to Consider Sohu.com carries a Zacks Rank #4 (Sell). A better-ranked stock in the broader technology sector is Lam Research Corporation LRCX, …
Note from dshort: The charts below have been updated based on the September 17th Federal Reserve Flow of Funds release for Q2. I've also used the Vanguard Total Market ETF for extrapolating the Q Ratio up to the present. The Q
More Stock News: This Is Bigger than the iPhone! It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a …
On a per-share basis, the Houston-based company said it had a loss of 58 cents. Losses, adjusted for stock option expense and amortization costs, came to 19 cents per share. The results surpassed Wall Street expectations. The …
NEW YORK (AP) - The stock market's steep decline this week has pushed the Dow Jones industrial average into what is known as "correction" territory. Here are some common questions asked about corrections and what they mean to …
This story was generated by Automated Insights using data from Zacks Investment Research. Access a Zacks stock report on DLR at https://www.zacks.com/ap/DLR
BOK Financial’s consistent revenue growth keeps us optimistic about the stock. Furthermore, continued growth in loan balances indicates an efficient organic …